查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886127

全球流感诊断市场

Influenza Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球流感诊断市场规模将达49亿美元。

全球流感诊断市场规模在2024年估计为36亿美元，预计2030年将达到49亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为5.2%。快速诊断测试（RIDT）是本报告分析的细分市场之一，预计复合年增长率将达到6.1%，并在分析期结束时达到20亿美元。 RT-PCR细分市场预计在分析期间内复合年增长率为5.1%。

美国市场规模估计为9.476亿美元，而中国市场预计将以8.0%的复合年增长率成长。

据估计，2024年美国流感诊断市场规模将达到9.476亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到11亿美元，在2024年至2030年的分析期间内，复合年增长率（CAGR）将达到8.0%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为2.7%和4.9%。在欧洲，德国预计将以约3.1%的复合年增长率成长。

全球流感诊断市场—主要市场趋势与驱动因素概述

目前流感诊断采用的技术是？

流感诊断对于有效的医疗保健至关重要，尤其是在应对季节性流行和潜在的大流行方面。目前的流感诊断技术包括快速流感诊断测试（RIDT）、逆转录-聚合酵素链锁反应（RT-PCR）和病毒培养。 RIDT 的优点在于快速出结果，可在 30 分钟内提供结果，有助于快速做出临床决策。然而，由于 RT-PCR 具有高灵敏度和特异性，能够区分不同的流感病毒株，因此被认为是流感诊断的黄金标准。病毒培养虽然由于週转时间较长而应用较少，但仍是流行病学研究和疫苗研发的重要工具。近年来，多重检测技术的出现取得了进展，该技术可以同时检测流感病毒和其他呼吸道病原体，从而提高了检测的效率和整体性。

患者需求如何改变流感诊断？

随着医疗保健消费者（患者）的认知水平不断提高，对快速、准确、便捷的诊断方法的需求日益增长。这种转变推动了照护现场（POC​​）技术的发展，这些检测可以在传统检查室以外的多种场所（例如药房和家中）进行。这些检测旨在方便使用者操作，只需极少的专业技能即可快速获得结果，从而缩短等待时间，加快启动适当的治疗。这种以患者为中心的方法不仅改善了个人健康状况，还有助于限制病毒在社区的传播，凸显了流感诊断的可及性和速度的重要性。

科技如何影响流感诊断的发展？

技术创新是流感诊断技术发展的主要驱动力。包括远端医疗和行动医疗应用在内的数位健康技术的兴起，在流感防治中发挥关键作用。这些技术能够实现远距离诊断和监测，这在流感高峰期和疫情大流行期间尤其重要，因为此时医疗机构往往不堪重负。此外，基因定序和生物资讯学的进步提高了病毒株鑑定的准确性和速度，这对于有效的治疗和疫苗策略至关重要。能够检测早期流感症状的生物感测器和穿戴式装置的开发，也是实现早期检测和介入的一个极具前景的研究方向。

流感诊断市场的成长受以下几个因素驱动：

流感诊断市场的成长受多种因素驱动，包括全球季节性流感发病率的上升以及人们对流感大流行威胁的日益关注。快速的都市化和国际旅行加速了病毒的传播，从而催生了对可靠诊断解决方案的全球性需求。诊断技术的进步，特别是快速检测和基因分析技术的进步，显着提高了流感诊断的反应速度和准确性。政府在感染疾病防治方面的措施和资金投入也进一步推动了诊断市场的扩张。此外，人工智慧（AI）和机器学习在诊断流程中的应用增强了数据分析和解读能力，从而实现了更精准、更具预测性的诊断。随着全球医疗卫生系统将预防性护理和早期疗育置于优先地位，对先进、快速的流感诊断解决方案的需求持续增长，确保了该领域的持续发展。

部分：

检测类型（快速诊断检测、RT-PCR、细胞培养、其他检测类型）、最终用途（医院、即时检测、检查室）

受访公司范例

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片文字稿、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在国、製造地以及进出口（成品和OEM产品）情况，预测企业竞争格局的变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响，包括销货成本增加、盈利下降和供应链重组，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12713

Global Influenza Diagnostics Market to Reach US$4.9 Billion by 2030

The global market for Influenza Diagnostics estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. RIDT, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis period. Growth in the RT-PCR segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$947.6 Million While China is Forecast to Grow at 8.0% CAGR

The Influenza Diagnostics market in the U.S. is estimated at US$947.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Influenza Diagnostics Market - Key Trends & Drivers Summarized

What Are the Current Technologies in Influenza Diagnostics?

Influenza diagnostics have become critical for effective healthcare delivery, especially in managing seasonal outbreaks and potential pandemics. Current technologies in influenza diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR), and viral cultures. RIDTs offer the advantage of speed, providing results in less than 30 minutes, which facilitates swift clinical decisions. However, RT-PCR is the gold standard for influenza diagnostics due to its high sensitivity and specificity, capable of distinguishing between different influenza strains. Viral culture, while less common due to its longer turnaround time, remains an important tool for epidemiological studies and vaccine development. Recent advancements also include the integration of multiplex assays that can detect influenza alongside other respiratory pathogens, enhancing the efficiency and comprehensiveness of testing.

How Are Patient Demands Transforming Influenza Diagnostics?

As healthcare consumers become more informed, there is a growing demand for quicker, more accurate diagnostic methods that can be accessed conveniently. This shift is driving the development of point-of-care (POC) tests that can be administered in various settings outside the traditional laboratory environment, such as pharmacies or at home. These tests are designed to be user-friendly, requiring minimal technical skills and providing rapid results to reduce the waiting period and accelerate the initiation of appropriate treatments. This patient-centric approach not only improves individual health outcomes but also aids in controlling the spread of the virus in community settings, highlighting the importance of accessibility and speed in influenza diagnostics.

What Impact Does Technology Have on the Evolution of Influenza Diagnostics?

Technological innovation is a key driver in the evolution of influenza diagnostics. The emergence of digital health technologies, including telehealth and mobile health apps, is playing a crucial role in the management of influenza. These technologies allow for remote diagnosis and monitoring, which is particularly beneficial during peak flu seasons or pandemics when healthcare facilities are overwhelmed. Additionally, advancements in genetic sequencing and bioinformatics have improved the accuracy and speed of strain identification, which is vital for effective treatment and vaccination strategies. The ongoing development of biosensors and wearable devices that can detect early symptoms of influenza represents another promising frontier, potentially enabling even earlier detection and intervention.

Growth in the Influenza Diagnostics Market Is Driven by Several Factors…

The growth in the influenza diagnostics market is driven by several factors, including the increased global incidence of seasonal influenza and heightened awareness of pandemic threats. Rapid urbanization and international travel contribute to the faster spread of the virus, necessitating robust diagnostic solutions globally. Advances in diagnostic technologies, particularly in rapid testing and genetic analysis, have significantly improved the response time and accuracy of influenza diagnostics. Government initiatives and funding for infectious disease control further support the expansion of the diagnostics market. Additionally, the integration of artificial intelligence and machine learning in diagnostic processes enhances data analysis and interpretation, leading to more precise and predictive diagnostics. As healthcare systems worldwide prioritize preventive care and early intervention, the demand for advanced, rapid influenza diagnostic solutions continues to rise, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Influenza Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (RIDT, RT-PCR, Cell Culture, Other Test Types); End-Use (Hospitals, POCT, Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 38 Featured) -

  • Alere, Inc.
  • Analytik Jena AG
  • Becton, Dickinson and Company
  • DiaSorin SpA
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Influenza Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Seasonal and Pandemic Influenza Spurs Demand for Rapid Diagnostic Solutions
    • Advancements in Molecular Diagnostic Technologies Propel Growth in Influenza Testing
    • Increasing Focus on Early Detection and Prevention Expands Addressable Market for Influenza Diagnostics
    • Growing Adoption of Point-of-Care Testing Drives Demand for Rapid Influenza Diagnostic Kits
    • Stringent Regulatory Approvals and Guidelines Strengthen Business Case for High-Accuracy Diagnostic Solutions
    • Rising Awareness of Flu Vaccination Correlates with Increased Demand for Diagnostic Testing
    • Innovation in Multiplex Assays Generates Opportunities for Comprehensive Respiratory Disease Screening
    • AI and Machine Learning Enhance Diagnostic Accuracy and Predictive Analytics in Influenza Testing
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Demand for At-Home Influenza Testing Kits
    • Increasing Healthcare Investments in Emerging Markets Propel Growth in Influenza Diagnostics
    • Rising Demand for Digital Health Platforms Drives Adoption of Connected Diagnostic Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RIDT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for RIDT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Culture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for POCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for POCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Influenza Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Influenza Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • JAPAN
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • CHINA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • EUROPE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Influenza Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • GERMANY
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Influenza Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • INDIA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Influenza Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Influenza Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Influenza Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030
  • AFRICA
    • Influenza Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Influenza Diagnostics by Test Type - RIDT, RT-PCR, Cell Culture and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Influenza Diagnostics by Test Type - Percentage Breakdown of Value Sales for RIDT, RT-PCR, Cell Culture and Other Test Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Influenza Diagnostics by End-Use - Hospitals, POCT and Laboratories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Influenza Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, POCT and Laboratories for the Years 2015, 2025 & 2030

IV. COMPETITION